DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gemzar (Gemcitabine Hydrochloride) - News

 
 



News related to Gemzar (Gemcitabine) and/or conditions it is approved for

Patients with EGFR expressing non-small-cell lung cancer benefit most from necitumumab added to chemotherapy
Source: Lung Cancer News From Medical News Today [2016.04.15]
Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit most from necitumumab added to gemcitabine and cisplatin chemotherapy...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015